Tag: bioequivalence studies

Learn what the FDA requires for bioequivalence studies, including the 80/125 rule, ANDA requirements, and how to use biowaivers to get generic drugs approved faster.

Crossover trial designs are the gold standard in bioequivalence studies, using each participant as their own control to reduce variability and sample size. Learn how 2x2 and replicate designs work, why washout periods matter, and how regulators assess drug equivalence.

Recent-posts

Generic vs Brand-Name Drugs: Key Differences Explained

Generic vs Brand-Name Drugs: Key Differences Explained

Jan, 30 2026

Panmycin (Tetracycline) vs Alternative Antibiotics: Detailed Comparison

Panmycin (Tetracycline) vs Alternative Antibiotics: Detailed Comparison

Oct, 17 2025

Immunogenicity in Biosimilars: Why Immune Responses May Differ from Reference Biologics

Immunogenicity in Biosimilars: Why Immune Responses May Differ from Reference Biologics

Feb, 1 2026

Large Print and Accessible Prescription Labels for Low Vision: What You Need to Know

Large Print and Accessible Prescription Labels for Low Vision: What You Need to Know

Dec, 26 2025

Chinese Generic Production: Manufacturing and Quality Concerns in 2026

Chinese Generic Production: Manufacturing and Quality Concerns in 2026

Jan, 10 2026